Macrophages and Therapeutic Resistance in Cancer

Macrophages and Therapeutic Resistance in Cancer

April 13, 2015 | Brian Ruffell and Lisa M. Coussens
Macrophages play a critical role in regulating the tumor microenvironment and influencing therapeutic responses in cancer. Their presence and activity can either promote or suppress tumor growth, depending on their polarization state. Therapies targeting macrophages, such as inhibitors of the CSF-1 receptor (CSF-1R), have shown promise in preclinical models and are being evaluated in clinical trials. These therapies aim to reduce the number of tumor-associated macrophages or reprogram them toward an anti-tumor phenotype. Macrophages can enhance tumor growth by promoting angiogenesis, supporting metastasis, and suppressing immune responses. They also contribute to therapeutic resistance by providing survival signals to cancer cells and modulating the tumor microenvironment. Understanding the molecular mechanisms underlying macrophage function and their interactions with other immune cells is essential for developing effective therapeutic strategies. Targeting macrophages offers a potential approach to improve treatment outcomes by enhancing anti-tumor immune responses and reducing tumor growth. Current research focuses on identifying the pathways that regulate macrophage polarization and function, as well as developing targeted therapies that can modulate these processes. The role of macrophages in cancer is complex and context-dependent, and further studies are needed to fully understand their impact on therapeutic responses and to develop more effective treatments.Macrophages play a critical role in regulating the tumor microenvironment and influencing therapeutic responses in cancer. Their presence and activity can either promote or suppress tumor growth, depending on their polarization state. Therapies targeting macrophages, such as inhibitors of the CSF-1 receptor (CSF-1R), have shown promise in preclinical models and are being evaluated in clinical trials. These therapies aim to reduce the number of tumor-associated macrophages or reprogram them toward an anti-tumor phenotype. Macrophages can enhance tumor growth by promoting angiogenesis, supporting metastasis, and suppressing immune responses. They also contribute to therapeutic resistance by providing survival signals to cancer cells and modulating the tumor microenvironment. Understanding the molecular mechanisms underlying macrophage function and their interactions with other immune cells is essential for developing effective therapeutic strategies. Targeting macrophages offers a potential approach to improve treatment outcomes by enhancing anti-tumor immune responses and reducing tumor growth. Current research focuses on identifying the pathways that regulate macrophage polarization and function, as well as developing targeted therapies that can modulate these processes. The role of macrophages in cancer is complex and context-dependent, and further studies are needed to fully understand their impact on therapeutic responses and to develop more effective treatments.
Reach us at info@study.space